We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

3 FTSE 100 and FTSE 250 value stocks I’d buy right now

The London Stock Exchange is packed with top value stocks offering low earnings multiples and big dividend yields. These three are on my shopping list.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Smiling family of four enjoying breakfast at sunrise while camping

Image source: Getty Images

I’m searching the FTSE 100 and FTSE 250 for the best value stocks that money can buy. Here are three I’ll be looking to add to my portfolio when I have extra cash to invest.

GSK

Failure at the lab bench can play havoc with drugs developers’ profits. Yet a growing global population and rising healthcare spending in developing countries provide a wealth of opportunities for such businesses.

FTSE 100 share GSK (LSE:GSK) is one such on my radar. It has a phenomenal track record of getting its products past regulators and onto pharmacy shelves. And it’s investing heavily in fast-growing therapy areas like vaccines, oncology and respiratory to give earnings an additional boost.

The company’s sale of $804m worth of Haleon shares late last week gives GSK’s shares extra appeal, too. The extra funds give it additional financial firepower to invest in its product pipeline. They also give it more balance sheet strength to pay decent dividends to its shareholders.

Today GSK’s share price commands a forward price-to-earnings (P/E) ratio of 10 times. They also carry a healthy 3.8% prospective dividend yield, proving attractive all-round value.

NCC Group

IT services businesses like NCC Group (LSE:NCC) haven’t had the best of times more recently. This UK share — an expert in the field of cyber security — cut its profit forecasts just over a month ago chiefly due to trouble in North America.

Tech sector troubles have caused clients to cancel or delay buying decisions, the firm said, while further interest rate rises had also sapped customer appetite. The collapse of Silicon Valley Bank had damaged tech market confidence and thus project spending, too.

But I believe these troubles are baked into NCC’s low share price. For the year to May 2024 the FTSE 250 firm trades on a P/E ratio of just 8 times.

As a long-term investor I find its shares highly attractive at current prices. Fixing cyber attacks is an expensive business (outsourcing giant Capita recently said that a security breach could cost it £20m). And the threat from hackers is steadily growing as the world becomes increasingly digitalised. I expect NCC to recover strongly from its current troubles.

TBC Bank Group

I’ve long had my eye on TBC Bank Group (LSE:TBCG) shares. I feel the company’s leading position in Georgia’s fast-growing banking industry could deliver exceptional returns. And following this week’s sizzling market update I’m considering finally adding it to my portfolio.

Net interest income and pre-tax profit soared 27% and 19% respectively in the first quarter. This was driven by rapid growth in the Georgian economy (7.2% during the period) and a jump in customer numbers (up 42% year on year to 14.8m).

Okay, banks are highly cyclical and growth at TBC could stall if the global economy encounters a fresh crisis. Yet in my opinion the FTSE 250 firm’s low valuation still makes it a top-class value stock to buy.

Today it trades on a forward P/E ratio of 3.9 times. It also sports a terrific 8.2% prospective dividend yield.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK and Haleon Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

2 UK shares to consider avoiding as the FTSE 100 extends losses

As the FTSE 100 dips for the second time this year, Mark Hartley weighs up market sentiment and considers two…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

How to invest £125 a month in UK shares to target a £39,039 annual passive income

Muhammad Cheema explains how an investor could earn the current median salary in the UK as passive income by making…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

These white-hot FTSE 250 growth shares are on sale today!

Royston Wild loves a good bargain. Here he reveals two FTSE 250 shares that all savvy UK stock investors should…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

How much do you need an ISA for a £31,352 second income?

Investing regularly in a Stocks and Shares ISA can generate a significant second income in retirement. Royston Wild explains how.

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

With the Aston Martin share price in pennies, is it in bargain territory?

With the Aston Martin share price at a fraction of what it once was, is it a bargain? Our writer…

Read more »

A hiker and their dog walking towards the mountain summit of High Spy from Maiden Moor at sunrise
Investing Articles

How I plan to lock in sustainable growth on the FTSE 100 in the coming years

Mark Hartley takes a sobering look at the future, and outlines a plan to target FTSE 100 sectors with lower…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

What are the FTSE’s most lucrative high-yield shares?

Our writer zooms in one one of a handful of high-yield FTSE 100 shares to explain why he thinks it…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

Why bother with a SIPP now rather than wait 10 years?

Interested in a SIPP but putting it off to give yourself time to think? Christopher Ruane explains why that could…

Read more »